Senate releases Avandia report, GSK responds to attacks

In the wake of Friday night’s New York Times story on the Avandia controversy (see our summary here), the Senate Finance Committee has posted its 334 page report, as well as a press release and the contents of its letter to FDA Commissioner Margaret Hamburg. GlaxoSmithKline has released its own press release in which the company rejects the conclusions reported in the story.

Here are links to the documents:

Trackbacks

  1. […] that were highly critical of Avandia and its continued availability. The Senate Finance committee then released the report on […]

  2. […] following the New York Times disclosure of FDA and Senate reports critical of rosiglitazone, the subsequent release of the Senate report, and the revelation that Steve Nissen had secretly recorded a meeting with GSK executives (though […]

  3. […] Senate releases Avandia report, GSK responds to attacks (February 20, 2010) […]

  4. […] Senate releases Avandia report, GSK responds to attacks (February 20, 2010) […]

  5. […] in June 2007 but were not fully aware of GlaxoSmithKline’s manipulations” until the publication of a senate report detailing the episode in February of this […]

  6. […] Senate releases Avandia report, GSK responds to attacks (February 20, 2010) […]

Speak Your Mind

*